Qian Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qian Li has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Xudong Wu
Tianjin Medical University
2 shared publications Chunmeng Yao
State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy and Tianjin Central Hospital of Gynecology Obstetrics/Tianjin Key Laboratory of Human Development and Reproductive Regulation, Nankai University, Tianjin 300350, China
1 shared publication- Dawei Huo
State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
1 shared publication - Deng Liu
State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
1 shared publication - Fan Wang
State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
1 shared publication - Francisco Morís
EntreChem SL, Vivero Ciencias de la Salud Calle Colegio, Oviedo, Spain
1 shared publication
Latest Publications
- 7 March 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (11) , 2100-2116
Targeting the SP/KLF Transcriptional Regulatory Network Synergizes with HDAC Inhibition to Impede Progression of H3K27M Diffuse Intrinsic Pontine Glioma
Diffuse intrinsic pontine gliomas (DIPG) are lethal pediatric brain tumors that frequently harbor H3K27M mutations and lack effective treatments. In this study, our epigenomic analyses uncovered an enrichment of specificity protein/Krüppel-like factor (SP/KLF) transcription factors in open chromatin regions specifically in H3K27M-mutated DIPG cells compared with normal pontine neural progenitor cells. SP1 depletion or inhibition of SP/KLF DNA binding with EC-8042, an optimized mithramycin analog, significantly suppressed the proliferation and invasiveness of H3K27M-DIPG cells. A screen of epigenetic drugs showed that histone deacetylase inhibitors (HDACi) synergized with EC-8042 to suppress H3K27M-DIPG cell growth. Unexpectedly, HDACis activated transcriptional programs that enhanced tumor adaptability and invasiveness, an effect counteracted by EC-8042. Mechanistically, HDACi treatment enhanced chromatin accessibility to SP/KLF factors, whereas EC-8042 disrupted both the primary SP/KLF transcription regulatory network and the HDACi-induced secondary network. Consequently, the combination treatment significantly impeded tumor progression in orthotopic xenograft models. Transcriptomic profiling indicated that this combinatorial strategy induced transcriptional changes associated with improved prognosis in patients with DIPG. Thus, this study identifies a therapeutic approach for H3K27M-mutated DIPGs and sheds light on the limitations of HDACis in treating solid tumors. Significance: The SP/KLF transcriptional regulatory network is activated in H3K27M-mutated diffuse intrinsic pontine glioma and represents a promising therapeutic target in combination with HDAC inhibitors for combating these lethal pediatric brain tumors.
- 7 March 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (11) , 2100-2116
Targeting the SP/KLF Transcriptional Regulatory Network Synergizes with HDAC Inhibition to Impede Progression of H3K27M Diffuse Intrinsic Pontine Glioma
Diffuse intrinsic pontine gliomas (DIPG) are lethal pediatric brain tumors that frequently harbor H3K27M mutations and lack effective treatments. In this study, our epigenomic analyses uncovered an enrichment of specificity protein/Krüppel-like factor (SP/KLF) transcription factors in open chromatin regions specifically in H3K27M-mutated DIPG cells compared with normal pontine neural progenitor cells. SP1 depletion or inhibition of SP/KLF DNA binding with EC-8042, an optimized mithramycin analog, significantly suppressed the proliferation and invasiveness of H3K27M-DIPG cells. A screen of epigenetic drugs showed that histone deacetylase inhibitors (HDACi) synergized with EC-8042 to suppress H3K27M-DIPG cell growth. Unexpectedly, HDACis activated transcriptional programs that enhanced tumor adaptability and invasiveness, an effect counteracted by EC-8042. Mechanistically, HDACi treatment enhanced chromatin accessibility to SP/KLF factors, whereas EC-8042 disrupted both the primary SP/KLF transcription regulatory network and the HDACi-induced secondary network. Consequently, the combination treatment significantly impeded tumor progression in orthotopic xenograft models. Transcriptomic profiling indicated that this combinatorial strategy induced transcriptional changes associated with improved prognosis in patients with DIPG. Thus, this study identifies a therapeutic approach for H3K27M-mutated DIPGs and sheds light on the limitations of HDACis in treating solid tumors. Significance: The SP/KLF transcriptional regulatory network is activated in H3K27M-mutated diffuse intrinsic pontine glioma and represents a promising therapeutic target in combination with HDAC inhibitors for combating these lethal pediatric brain tumors.
- Open Access
- 22 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (51) , eadi5683
Haploid-genetic screening of trophectoderm specification identifies Dyrk1a as a repressor of totipotent-like status
Trophectoderm (TE) and the inner cell mass are the first two lineages in murine embryogenesis and cannot naturally transit to each other. The barriers between them are unclear and fascinating. Embryonic stem cells (ESCs) and trophoblast stem cells (TSCs) retain the identities of inner cell mass and TE, respectively, and, thus, are ideal platforms to investigate these lineages in vitro. Here, we develop a loss-of-function genetic screening in haploid ESCs and reveal many mutations involved in the conversion of TSCs. The disruption of either Catip or Dyrk1a (candidates) in ESCs facilitates the conversion of TSCs. According to transcriptome analysis, we find that the repression of Dyrk1a activates totipotency, which is a possible reason for TE specification. Dyrk1a -null ESCs can contribute to embryonic and extraembryonic tissues in chimeras and can efficiently form blastocyst-like structures, indicating their totipotent developmental abilities. These findings provide insights into the mechanisms underlying cell fate alternation in embryogenesis.
- 22 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (51) , eadi5683
Open AccessHaploid-genetic screening of trophectoderm specification identifies Dyrk1a as a repressor of totipotent-like status
Trophectoderm (TE) and the inner cell mass are the first two lineages in murine embryogenesis and cannot naturally transit to each other. The barriers between them are unclear and fascinating. Embryonic stem cells (ESCs) and trophoblast stem cells (TSCs) retain the identities of inner cell mass and TE, respectively, and, thus, are ideal platforms to investigate these lineages in vitro. Here, we develop a loss-of-function genetic screening in haploid ESCs and reveal many mutations involved in the conversion of TSCs. The disruption of either Catip or Dyrk1a (candidates) in ESCs facilitates the conversion of TSCs. According to transcriptome analysis, we find that the repression of Dyrk1a activates totipotency, which is a possible reason for TE specification. Dyrk1a -null ESCs can contribute to embryonic and extraembryonic tissues in chimeras and can efficiently form blastocyst-like structures, indicating their totipotent developmental abilities. These findings provide insights into the mechanisms underlying cell fate alternation in embryogenesis.
- 15 May 2020
- Published by Pleiades Publishing Ltd in Russian Journal of Plant Physiology
- Vol. 67 (3) , 443-452
Transcriptome Analysis Reveals Genetic Basis of Differences in Bioactive Compound Biosynthesis between Rhizome and Aboveground Stem in Ginger (Zingiber officinale Rosc.)
Ginger (Zingiber officinale Rosc.) is a valuable food and medicinal plant. Its pharmacological activities are mainly attributed to its secondary metabolites. As a non-model plant, there is a lack of reference sequence information for ginger. Understanding the molecular mechanism of the biosynthesis of active compounds has important practical value for molecular breeding and the medicinal use of ginger. Gingerol constituents differ substantially between the aboveground stem and underground rhizome, with gingerols mainly accumulating in the rhizome. Therefore, de novo transcriptome sequencing was performed compare the expression of genes related to secondary metabolite biosynthesis between the two tissues. We obtained 219 479 unigenes after removing low-mass and linker sequences. The unigenes were assembled using Trinity software and compared with the Swiss-Prot, Nr, and KEGG databases for functional annotation. The differentially expressed genes (DEGs) between ginger rhizome (Rh-M) and stem (St-M) samples met the following criteria: FDR ≤ 0.005 and |log 2-fold change| ≥ 3. In total, there were 1418 DEGs between the two tissues (611 genes upregulated in Rh-M vs. St-M and 807 genes downregulated). 11 of these DEGs upregulated in the rhizome were related to the biosynthesis of pharmacologically active compounds, particularly terpenoids, diarylheptanoids, gingerols, and flavonoids, and to plant hormone signal transduction. We speculate that plant hormone signaling might play roles in regulating the biosynthesis of gingerols and other metabolites in the phenylpropane metabolic pathway in the rhizome. These results provide genome resources and information that will be useful for the molecular breeding in ginger.
- 15 May 2020
- Published by Pleiades Publishing Ltd in Russian Journal of Plant Physiology
- Vol. 67 (3) , 443-452
Transcriptome Analysis Reveals Genetic Basis of Differences in Bioactive Compound Biosynthesis between Rhizome and Aboveground Stem in Ginger (Zingiber officinale Rosc.)
Ginger (Zingiber officinale Rosc.) is a valuable food and medicinal plant. Its pharmacological activities are mainly attributed to its secondary metabolites. As a non-model plant, there is a lack of reference sequence information for ginger. Understanding the molecular mechanism of the biosynthesis of active compounds has important practical value for molecular breeding and the medicinal use of ginger. Gingerol constituents differ substantially between the aboveground stem and underground rhizome, with gingerols mainly accumulating in the rhizome. Therefore, de novo transcriptome sequencing was performed compare the expression of genes related to secondary metabolite biosynthesis between the two tissues. We obtained 219 479 unigenes after removing low-mass and linker sequences. The unigenes were assembled using Trinity software and compared with the Swiss-Prot, Nr, and KEGG databases for functional annotation. The differentially expressed genes (DEGs) between ginger rhizome (Rh-M) and stem (St-M) samples met the following criteria: FDR ≤ 0.005 and |log 2-fold change| ≥ 3. In total, there were 1418 DEGs between the two tissues (611 genes upregulated in Rh-M vs. St-M and 807 genes downregulated). 11 of these DEGs upregulated in the rhizome were related to the biosynthesis of pharmacologically active compounds, particularly terpenoids, diarylheptanoids, gingerols, and flavonoids, and to plant hormone signal transduction. We speculate that plant hormone signaling might play roles in regulating the biosynthesis of gingerols and other metabolites in the phenylpropane metabolic pathway in the rhizome. These results provide genome resources and information that will be useful for the molecular breeding in ginger.